ID   MTNN_ECOLI              Reviewed;         232 AA.
AC   P0AF12; P24247;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 1.
DT   15-MAR-2017, entry version 102.
DE   RecName: Full=5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase;
DE            Short=MTA/SAH nucleosidase;
DE            Short=MTAN;
DE            EC=3.2.2.9;
DE   AltName: Full=5'-methylthioadenosine nucleosidase;
DE            Short=MTA nucleosidase;
DE   AltName: Full=P46;
DE   AltName: Full=S-adenosylhomocysteine nucleosidase;
DE            Short=AdoHcy nucleosidase;
DE            Short=SAH nucleosidase;
DE            Short=SRH nucleosidase;
GN   Name=mtnN; Synonyms=mtn, pfs, yadA; OrderedLocusNames=b0159, JW0155;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RX   PubMed=2157212; DOI=10.1073/pnas.87.7.2740;
RA   Wurgler S.M., Richardson C.C.;
RT   "Structure and regulation of the gene for dGTP triphosphohydrolase
RT   from Escherichia coli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:2740-2744(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND CHARACTERIZATION.
RX   PubMed=9524204; DOI=10.1016/S0167-4781(97)00169-3;
RA   Cornell K.A., Riscoe M.K.;
RT   "Cloning and expression of Escherichia coli 5'-methylthioadenosine/S-
RT   adenosylhomocysteine nucleosidase: identification of the pfs gene
RT   product.";
RL   Biochim. Biophys. Acta 1396:8-14(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=8202364; DOI=10.1093/nar/22.9.1637;
RA   Fujita N., Mori H., Yura T., Ishihama A.;
RT   "Systematic sequencing of the Escherichia coli genome: analysis of the
RT   2.4-4.1 min (110,917-193,643 bp) region.";
RL   Nucleic Acids Res. 22:1637-1639(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RA   Chung E., Allen E., Araujo R., Aparicio A.M., Davis K., Duncan M.,
RA   Federspiel N., Hyman R., Kalman S., Komp C., Kurdi O., Lew H., Lin D.,
RA   Namath A., Oefner P., Roberts D., Schramm S., Davis R.W.;
RT   "Sequence of minutes 4-25 of Escherichia coli.";
RL   Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [7]
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND ENZYME REGULATION.
RX   PubMed=3911944;
RA   Della Ragione F., Porcelli M., Carteni-Farina M., Zappia V.,
RA   Pegg A.E.;
RT   "Escherichia coli S-adenosylhomocysteine/5'-methylthioadenosine
RT   nucleosidase. Purification, substrate specificity and mechanism of
RT   action.";
RL   Biochem. J. 232:335-341(1985).
RN   [8]
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND ENZYME REGULATION.
RX   PubMed=8941345; DOI=10.1006/bbrc.1996.1723;
RA   Cornell K.A., Swarts W.E., Barry R.D., Riscoe M.K.;
RT   "Characterization of recombinant Eschericha coli 5'-
RT   methylthioadenosine/S-adenosylhomocysteine nucleosidase: analysis of
RT   enzymatic activity and substrate specificity.";
RL   Biochem. Biophys. Res. Commun. 228:724-732(1996).
RN   [9]
RP   IDENTIFICATION BY 2D-GEL.
RX   PubMed=9298644; DOI=10.1002/elps.1150180805;
RA   VanBogelen R.A., Abshire K.Z., Moldover B., Olson E.R.,
RA   Neidhardt F.C.;
RT   "Escherichia coli proteome analysis using the gene-protein database.";
RL   Electrophoresis 18:1243-1251(1997).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, KINETIC PARAMETERS, AND MUTAGENESIS OF
RP   MET-9; GLU-12; ILE-50; SER-76; PHE-151; MET-173; GLU-174; ARG-193;
RP   SER-196; ASP-197 AND PHE-207.
RX   PubMed=16101288; DOI=10.1021/bi050493q;
RA   Lee J.E., Luong W., Huang D.J., Cornell K.A., Riscoe M.K.,
RA   Howell P.L.;
RT   "Mutational analysis of a nucleosidase involved in quorum-sensing
RT   autoinducer-2 biosynthesis.";
RL   Biochemistry 44:11049-11057(2005).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) IN COMPLEX WITH SUBSTRATE, AND
RP   SUBUNIT.
RX   PubMed=11591349; DOI=10.1016/S0969-2126(01)00656-6;
RA   Lee J.E., Cornell K.A., Riscoe M.K., Howell P.L.;
RT   "Structure of E. coli 5'-methylthioadenosine/S-adenosylhomocysteine
RT   nucleosidase reveals similarity to the purine nucleoside
RT   phosphorylases.";
RL   Structure 9:941-953(2001).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH SUBSTRATE
RP   ANALOGS, AND ENZYME REGULATION.
RX   PubMed=12496243; DOI=10.1074/jbc.M210836200;
RA   Lee J.E., Cornell K.A., Riscoe M.K., Howell P.L.;
RT   "Structure of Escherichia coli 5'-methylthioadenosine/ S-
RT   adenosylhomocysteine nucleosidase inhibitor complexes provide insight
RT   into the conformational changes required for substrate binding and
RT   catalysis.";
RL   J. Biol. Chem. 278:8761-8770(2003).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) IN COMPLEX WITH SUBSTRATE
RP   ANALOGS, AND ENZYME REGULATION.
RX   PubMed=15749708; DOI=10.1074/jbc.M414472200;
RA   Singh V., Evans G.B., Lenz D.H., Mason J.M., Clinch K., Mee S.,
RA   Painter G.F., Tyler P.C., Furneaux R.H., Lee J.E., Howell P.L.,
RA   Schramm V.L.;
RT   "Femtomolar transition state analogue inhibitors of 5'-
RT   methylthioadenosine/S-adenosylhomocysteine nucleosidase from
RT   Escherichia coli.";
RL   J. Biol. Chem. 280:18265-18273(2005).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF WILD-TYPE AND MUTANTS ASN-197
RP   AND GLN-12 IN COMPLEX WITH MTA SUBSTRATE OR PRODUCTS, REACTION
RP   MECHANISM, AND ACTIVE SITES.
RX   PubMed=16109423; DOI=10.1016/j.jmb.2005.07.027;
RA   Lee J.E., Smith G.D., Horvatin C., Huang D.J., Cornell K.A.,
RA   Riscoe M.K., Howell P.L.;
RT   "Structural snapshots of MTA/AdoHcy nucleosidase along the reaction
RT   coordinate provide insights into enzyme and nucleoside flexibility
RT   during catalysis.";
RL   J. Mol. Biol. 352:559-574(2005).
CC   -!- FUNCTION: Catalyzes the irreversible cleavage of the glycosidic
CC       bond in both 5'-methylthioadenosine (MTA) and S-
CC       adenosylhomocysteine (SAH/AdoHcy) to adenine and the corresponding
CC       thioribose, 5'-methylthioribose and S-ribosylhomocysteine,
CC       respectively. Can also use 5'-isobutylthioadenosine, 5'-n-
CC       butylthioadenosine, S-adenosyl-D-homocysteine, decarboxylated
CC       adenosylhomocysteine, deaminated adenosylhomocysteine and S-2-aza-
CC       adenosylhomocysteine as substrates. {ECO:0000269|PubMed:16101288}.
CC   -!- CATALYTIC ACTIVITY: S-adenosyl-L-homocysteine + H(2)O = S-(5-
CC       deoxy-D-ribos-5-yl)-L-homocysteine + adenine.
CC       {ECO:0000269|PubMed:16101288}.
CC   -!- CATALYTIC ACTIVITY: S-methyl-5'-thioadenosine + H(2)O = S-methyl-
CC       5-thio-D-ribose + adenine. {ECO:0000269|PubMed:16101288}.
CC   -!- ENZYME REGULATION: Strongly inhibited by aryl-substituted MTA
CC       analogs, alkyl-substituted MTA analogs, 5'-methylthioformycin, 5'-
CC       chloroformycin, S-formycinylhomocysteine, 5'-methylthiotubercidin,
CC       S-tubercidinylhomocysteine and S-8-aza-adenosylhomocysteine.
CC       Poorly inhibited by 5'-isobutylthioinosine, 5'-n-butylthioinosine,
CC       5'-methylthio-3-deaza-adenosine, 5'-isobutylthio-3-deaza-
CC       adenosine, S-n-6-methyl-3-deaza-adenosylhomocysteine, S-
CC       adenosylhomocysteine sulphoxide and Sinefungin.
CC       {ECO:0000269|PubMed:12496243, ECO:0000269|PubMed:15749708,
CC       ECO:0000269|PubMed:3911944, ECO:0000269|PubMed:8941345}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.43 uM for 5'-methylthioadenosine (at pH 7 and 37 degrees
CC         Celsius) {ECO:0000269|PubMed:16101288,
CC         ECO:0000269|PubMed:3911944, ECO:0000269|PubMed:8941345};
CC         KM=0.8 uM for 5'-methylthioadenosine (at pH 7 and 22 degrees
CC         Celsius) {ECO:0000269|PubMed:16101288,
CC         ECO:0000269|PubMed:3911944, ECO:0000269|PubMed:8941345};
CC         KM=4.3 uM for S-adenosylhomocysteine (at pH 7 and 37 degrees
CC         Celsius) {ECO:0000269|PubMed:16101288,
CC         ECO:0000269|PubMed:3911944, ECO:0000269|PubMed:8941345};
CC         KM=1.3 uM for S-adenosylhomocysteine (at pH 7 and 22 degrees
CC         Celsius) {ECO:0000269|PubMed:16101288,
CC         ECO:0000269|PubMed:3911944, ECO:0000269|PubMed:8941345};
CC         Vmax=373 umol/min/mg enzyme with 5'-methylthioadenosine as
CC         substrate (at pH 7 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:16101288, ECO:0000269|PubMed:3911944,
CC         ECO:0000269|PubMed:8941345};
CC         Vmax=156 umol/min/mg enzyme with S-adenosylhomocysteine as
CC         substrate (at pH 7 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:16101288, ECO:0000269|PubMed:3911944,
CC         ECO:0000269|PubMed:8941345};
CC         Note=kcat is 3.0 sec(-1) and 2.6 sec(-1) with 5'-
CC         methylthioadenosine and S-adenosylhomocysteine as substrate,
CC         respectively. {ECO:0000269|PubMed:16101288};
CC       pH dependence:
CC         Exhibits activity across a broad pH range. Enzyme activity is
CC         moderately improved under acidic conditions.
CC         {ECO:0000269|PubMed:3911944, ECO:0000269|PubMed:8941345};
CC       Temperature dependence:
CC         Optimum temperature is 37-45 degrees Celsius. Rapidly
CC         inactivated after exposure for 10 minutes at 55 degrees Celsius.
CC         {ECO:0000269|PubMed:3911944, ECO:0000269|PubMed:8941345};
CC   -!- PATHWAY: Amino-acid biosynthesis; L-methionine biosynthesis via
CC       salvage pathway; S-methyl-5-thio-alpha-D-ribose 1-phosphate from
CC       S-methyl-5'-thioadenosine (hydrolase route): step 1/2.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:11591349,
CC       ECO:0000269|PubMed:12496243, ECO:0000269|PubMed:15749708,
CC       ECO:0000269|PubMed:16109423}.
CC   -!- SIMILARITY: Belongs to the PNP/UDP phosphorylase family. MtnN
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA23678.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M31772; AAA23678.1; ALT_INIT; Genomic_DNA.
DR   EMBL; U24438; AAC38291.1; -; Genomic_DNA.
DR   EMBL; M83735; AAA24322.1; -; Genomic_DNA.
DR   EMBL; U70214; AAB08589.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC73270.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAB96736.1; -; Genomic_DNA.
DR   PIR; S45227; S45227.
DR   RefSeq; NP_414701.1; NC_000913.3.
DR   RefSeq; WP_000689844.1; NZ_LN832404.1.
DR   PDB; 1JYS; X-ray; 1.90 A; A/B=1-232.
DR   PDB; 1NC1; X-ray; 2.00 A; A/B=1-232.
DR   PDB; 1NC3; X-ray; 2.20 A; A/B=1-232.
DR   PDB; 1Y6Q; X-ray; 2.20 A; A/B=1-232.
DR   PDB; 1Y6R; X-ray; 2.20 A; A/B=1-232.
DR   PDB; 1Z5N; X-ray; 2.10 A; A/B=1-232.
DR   PDB; 1Z5O; X-ray; 2.00 A; A/B=1-232.
DR   PDB; 1Z5P; X-ray; 2.00 A; A=1-232.
DR   PDB; 3O4V; X-ray; 1.75 A; A/B=1-232.
DR   PDB; 4WKC; X-ray; 1.64 A; A=1-232.
DR   PDB; 4YML; X-ray; 1.75 A; A=1-232.
DR   PDBsum; 1JYS; -.
DR   PDBsum; 1NC1; -.
DR   PDBsum; 1NC3; -.
DR   PDBsum; 1Y6Q; -.
DR   PDBsum; 1Y6R; -.
DR   PDBsum; 1Z5N; -.
DR   PDBsum; 1Z5O; -.
DR   PDBsum; 1Z5P; -.
DR   PDBsum; 3O4V; -.
DR   PDBsum; 4WKC; -.
DR   PDBsum; 4YML; -.
DR   ProteinModelPortal; P0AF12; -.
DR   SMR; P0AF12; -.
DR   BioGrid; 4260991; 6.
DR   DIP; DIP-10270N; -.
DR   IntAct; P0AF12; 7.
DR   STRING; 511145.b0159; -.
DR   BindingDB; P0AF12; -.
DR   ChEMBL; CHEMBL2866; -.
DR   DrugBank; DB02933; 5'-Deoxy-5'-(Methylthio)-Tubercidin.
DR   DrugBank; DB00173; Adenine.
DR   DrugBank; DB02281; Formycin.
DR   SWISS-2DPAGE; P0AF12; -.
DR   EPD; P0AF12; -.
DR   PaxDb; P0AF12; -.
DR   PRIDE; P0AF12; -.
DR   EnsemblBacteria; AAC73270; AAC73270; b0159.
DR   EnsemblBacteria; BAB96736; BAB96736; BAB96736.
DR   GeneID; 948542; -.
DR   KEGG; ecj:JW0155; -.
DR   KEGG; eco:b0159; -.
DR   PATRIC; 32115427; VBIEscCol129921_0165.
DR   EchoBASE; EB1082; -.
DR   EcoGene; EG11090; pfs.
DR   eggNOG; ENOG4105DUF; Bacteria.
DR   eggNOG; COG0775; LUCA.
DR   HOGENOM; HOG000259346; -.
DR   InParanoid; P0AF12; -.
DR   KO; K01243; -.
DR   OMA; LLERCKP; -.
DR   PhylomeDB; P0AF12; -.
DR   BioCyc; EcoCyc:EG11090-MONOMER; -.
DR   BioCyc; MetaCyc:EG11090-MONOMER; -.
DR   BRENDA; 3.2.2.30; 2026.
DR   BRENDA; 3.2.2.9; 2026.
DR   UniPathway; UPA00904; UER00871.
DR   EvolutionaryTrace; P0AF12; -.
DR   PRO; PR:P0AF12; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0008782; F:adenosylhomocysteine nucleosidase activity; IDA:EcoCyc.
DR   GO; GO:0008930; F:methylthioadenosine nucleosidase activity; IDA:EcoCyc.
DR   GO; GO:0019509; P:L-methionine salvage from methylthioadenosine; IEA:UniProtKB-UniPathway.
DR   GO; GO:0019284; P:L-methionine salvage from S-adenosylmethionine; IDA:EcoCyc.
DR   GO; GO:0009164; P:nucleoside catabolic process; IEA:InterPro.
DR   Gene3D; 3.40.50.1580; -; 1.
DR   HAMAP; MF_01684; Salvage_MtnN; 1.
DR   InterPro; IPR010049; MTA_SAH_Nsdase.
DR   InterPro; IPR000845; Nucleoside_phosphorylase_d.
DR   Pfam; PF01048; PNP_UDP_1; 1.
DR   SUPFAM; SSF53167; SSF53167; 1.
DR   TIGRFAMs; TIGR01704; MTA/SAH-Nsdase; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Amino-acid biosynthesis; Complete proteome; Hydrolase;
KW   Methionine biosynthesis; Reference proteome.
FT   CHAIN         1    232       5'-methylthioadenosine/S-
FT                                adenosylhomocysteine nucleosidase.
FT                                /FTId=PRO_0000164439.
FT   REGION      173    174       Substrate binding.
FT   ACT_SITE     12     12       Proton acceptor.
FT                                {ECO:0000305|PubMed:16109423}.
FT   ACT_SITE    197    197       Proton donor.
FT                                {ECO:0000305|PubMed:16109423}.
FT   BINDING      78     78       Substrate; via amide nitrogen.
FT                                {ECO:0000269|PubMed:11591349}.
FT   BINDING     152    152       Substrate; via amide nitrogen and
FT                                carbonyl oxygen.
FT                                {ECO:0000269|PubMed:11591349}.
FT   MUTAGEN       9      9       M->A: 13-19% of wild-type catalytic
FT                                efficiency.
FT                                {ECO:0000269|PubMed:16101288}.
FT   MUTAGEN      12     12       E->A,Q: Loss of catalytic activity.
FT                                {ECO:0000269|PubMed:16101288}.
FT   MUTAGEN      50     50       I->A: 12-23% of wild-type catalytic
FT                                efficiency.
FT                                {ECO:0000269|PubMed:16101288}.
FT   MUTAGEN      76     76       S->A: 13-23% of wild-type catalytic
FT                                efficiency.
FT                                {ECO:0000269|PubMed:16101288}.
FT   MUTAGEN     151    151       F->A: 0.5% of wild-type catalytic
FT                                efficiency.
FT                                {ECO:0000269|PubMed:16101288}.
FT   MUTAGEN     173    173       M->A: 0.5% of wild-type catalytic
FT                                efficiency.
FT                                {ECO:0000269|PubMed:16101288}.
FT   MUTAGEN     174    174       E->A,Q: Loss of catalytic activity.
FT                                {ECO:0000269|PubMed:16101288}.
FT   MUTAGEN     193    193       R->A: 13-28% of wild-type catalytic
FT                                efficiency.
FT                                {ECO:0000269|PubMed:16101288}.
FT   MUTAGEN     196    196       S->A: 2-4% of wild-type catalytic
FT                                efficiency.
FT                                {ECO:0000269|PubMed:16101288}.
FT   MUTAGEN     197    197       D->A,N: Loss of catalytic activity.
FT                                {ECO:0000269|PubMed:16101288}.
FT   MUTAGEN     207    207       F->A: 2% of wild-type catalytic
FT                                efficiency.
FT                                {ECO:0000269|PubMed:16101288}.
FT   CONFLICT    212    232       AVAAKQSSLMVESLVQKLAHG -> LLPLNSPA (in
FT                                Ref. 1; AAA23678/AAA24322).
FT                                {ECO:0000305}.
FT   STRAND        2      9       {ECO:0000244|PDB:3O4V}.
FT   HELIX        10     17       {ECO:0000244|PDB:3O4V}.
FT   STRAND       21     28       {ECO:0000244|PDB:3O4V}.
FT   STRAND       31     38       {ECO:0000244|PDB:3O4V}.
FT   STRAND       41     47       {ECO:0000244|PDB:3O4V}.
FT   HELIX        52     66       {ECO:0000244|PDB:3O4V}.
FT   STRAND       69     79       {ECO:0000244|PDB:3O4V}.
FT   STRAND       89     99       {ECO:0000244|PDB:3O4V}.
FT   HELIX       103    105       {ECO:0000244|PDB:3O4V}.
FT   STRAND      117    120       {ECO:0000244|PDB:3O4V}.
FT   HELIX       123    135       {ECO:0000244|PDB:3O4V}.
FT   STRAND      140    147       {ECO:0000244|PDB:3O4V}.
FT   HELIX       155    164       {ECO:0000244|PDB:3O4V}.
FT   STRAND      168    174       {ECO:0000244|PDB:3O4V}.
FT   HELIX       175    185       {ECO:0000244|PDB:3O4V}.
FT   STRAND      189    197       {ECO:0000244|PDB:3O4V}.
FT   HELIX       203    231       {ECO:0000244|PDB:3O4V}.
SQ   SEQUENCE   232 AA;  24354 MW;  9B1FF9BEC39D4F2C CRC64;
     MKIGIIGAME EEVTLLRDKI ENRQTISLGG CEIYTGQLNG TEVALLKSGI GKVAAALGAT
     LLLEHCKPDV IINTGSAGGL APTLKVGDIV VSDEARYHDA DVTAFGYEYG QLPGCPAGFK
     ADDKLIAAAE ACIAELNLNA VRGLIVSGDA FINGSVGLAK IRHNFPQAIA VEMEATAIAH
     VCHNFNVPFV VVRAISDVAD QQSHLSFDEF LAVAAKQSSL MVESLVQKLA HG
//
